Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 816
Guide Official Revision Description Reason for Update
Version Date Number Of Change
should be submitted.
2024 03/27/2024 15. Medical Policy In Pharmaceuticals, Weight
Loss Medication, revised
Conditionally Acceptable
Weight Loss Medication
section to remove criteria
“when 2 more components
are used.” Also added
hyperlink to Weight Loss
Management Status Report.
2024 03/27/2024 16. Medical Policy Coumadin brand name for
warfarin has been
discontinued in the US and
replace by brand name
Jantoven. All references to
Coumadin were removed
from the AME Guide and
replaced with
warfarin/Jantoven.
References in the Archives
remain intact to document
historical usage.
2024 03/27/2024 17. Medical Policy In Protocol for Neurologic
Evaluation, revised. For
EEG, provide both
interpretive report (on paper)
and tracings (on a CD with
embedded stand-alone
viewing software).
2024 03/27/2024 18. Administrative On main listing for Disease
Protocols, added hyperlinks
to Protocol for Coronary
st nd
Heart Disease – 1 and 2
Class and to Protocol for
Coronary Heart Disease –
rd
3 class.
2024 03/27/2024 19. Administrative In Item 58., ECG, Equipment
Requirements, revised to
clarify that FAA criteria is the
standard voltage of
25mm/sec at 10mV.
2024 03/27/2024 20. Administrative In General Information, Item
19. Protection and
Destruction of Forms,
revised language to be more
concise.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
